1-(2-Fluorophenyl)-4-[2-(trifluoromethyl)benzenesulfonyl]piperazine

Catalog No.: 
ACHWHF765
CAS No.: 
1024234-52-3
Molecular Formula: 
C17H16F4N2O2S
Molecular Weight: 
388.39
1-(2-Fluorophenyl)-4-[2-(trifluoromethyl)benzenesulfonyl]piperazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg90%$88.00InquiryInquiry
1g90%$279.00InquiryInquiry
5g90%$1381.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(2-Fluorophenyl)-4-[2-(trifluoromethyl)benzenesulfonyl]piperazine
IUPAC Name1-(2-fluorophenyl)-4-((2-(trifluoromethyl)phenyl)sulfonyl)piperazine
Molecular FormulaC17H16F4N2O2S
Molecular Weight388.39
SMILESO=S(N1CCN(C2=CC=CC=C2F)CC1)(C3=CC=CC=C3C(F)(F)F)=O
InChI KeyHWVVYEZGDJHMCJ-UHFFFAOYSA-N
Synonym1-(2-fluorophenyl)-4-{[2-(trifluoromethyl)phenyl]sulfonyl}piperazine;Piperazine, 1-(2-fluorophenyl)-4-[[2-(trifluoromethyl)phenyl]sulfonyl]-
CAS No.1024234-52-3

Synthetic Route by SureRoute

1. ACHWHF765 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLAGT540 route compound structure diagram
    ACLAGT540776-04-5In Stock
  4. Then
  5. ACHWHF765 route product structure diagram
    ACHWHF7651024234-52-3
Inquiry

2. ACHWHF765 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACELZQ826 route compound structure diagram
    ACELZQ8261566233-22-4In Stock
  4. Then
  5. ACHWHF765 route product structure diagram
    ACHWHF7651024234-52-3
Inquiry

3. ACHWHF765 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHWHF765 route product structure diagram
    ACHWHF7651024234-52-3
Inquiry

Comments (0)